AR and small cell lung carcinoma: Devarakonda et al. provided the widest study of genomic profiling of SCLC using Guardant360 platform on ctDNA from 564 patients and highlighted the identification of potentially targetable alterations involving the androgen receptor gene (AR), the RTK/RAS pathway, or genes involved in DNA repair [26].